Search

3i Group PLC

Fermé

SecteurIndices

2,299 0.57

Résumé

Variation du prix de l'action

24h

Actuel

Min

2298

Max

2324

Chiffres clés

By Trading Economics

Revenu

-1.3B

2B

Ventes

44M

236M

P/E

Moyenne du Secteur

4.295

19.461

BPA

3.4

Rendement du dividende

3.66

Marge bénéficiaire

850.424

Employés

223

EBITDA

-745M

2B

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+36.98% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

3.66%

3.47%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-1.3B

24B

Ouverture précédente

2298.43

Clôture précédente

2299

Sentiment de l'Actualité

By Acuity

52%

48%

16 / 26 Classement par Indices

3i Group PLC Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 mai 2026, 08:38 UTC

Résultats
Principaux Mouvements du Marché

3i Group Shares Plunge After Slowdown at Retailer Action

29 janv. 2026, 16:27 UTC

Principaux Mouvements du Marché

U.K. Private Equity Group 3i's Shares Surge on Strong Sales at Key Asset

13 nov. 2025, 10:02 UTC

Résultats
Principaux Mouvements du Marché

3i Group Shares Tumble After Cautious Outlook

14 mai 2026, 09:08 UTC

Market Talk
Résultats

3i Group Suffers as Problems Mount at Retailer Action -- Market Talk

14 mai 2026, 07:04 UTC

Market Talk
Résultats

3i Group Buyback Might Be Eclipsed by Concerns on Key Holding Action -- Market Talk

14 mai 2026, 06:07 UTC

Résultats

3i Group: Private Equity Business Delivered Gross Investment Return of GBP5.30B in FY26

14 mai 2026, 06:06 UTC

Résultats

3i Group: Action Remained Significant Driver of Group's Performance in FY26

14 mai 2026, 06:05 UTC

Résultats

3i Group: FY2026 Total Return of GBP5.30B

14 mai 2026, 06:05 UTC

Résultats

3i Group Received GBP1.9B of Cash Proceeds From Portfolio in FY 2026

14 mai 2026, 06:04 UTC

Résultats

3i Group: Expect to See an Increase in Inflation Over Coming Months

14 mai 2026, 06:04 UTC

Résultats

3i Group: Market Environment Remains Complex Due to Middle East Situation

14 mai 2026, 06:03 UTC

Résultats

3i Group Declares Second Interim Dividend of 48p a Share

14 mai 2026, 06:02 UTC

Résultats

3i Group Plans Buyback of Up to GBP750M

14 mai 2026, 06:00 UTC

Résultats

3i FY Pretax Pft GBP5.29B

14 mai 2026, 06:00 UTC

Résultats

3i FY NAV/Shr GBP30.30

14 mai 2026, 06:00 UTC

Résultats

3i FY Net Pft GBP5.29B

14 mai 2026, 06:00 UTC

Résultats

3i FY EPS GBP5.386

26 mars 2026, 14:12 UTC

Market Talk
Principaux Événements d'Actualité

Action, 3i Group's Flagship Holding, Suffers from Bleak Outlook for Discount Retailers -- Market Talk

29 janv. 2026, 14:18 UTC

Market Talk
Résultats

3i Group's Value Proposition Built on Discount Retailer -- Market Talk

29 janv. 2026, 08:47 UTC

Market Talk
Résultats

3i Faces Tough Conditions in France, Competition from Chinese E-Tailers -- Market Talk

29 janv. 2026, 07:06 UTC

Résultats

3i Group Gross Cash at Dec. 31 GBP995M

29 janv. 2026, 07:04 UTC

Résultats

3i Group: Action Gross Cash at Dec. 31 Was EUR807M

29 janv. 2026, 07:02 UTC

Résultats

3i Group: Action LFL Sales Up 6.1% in First Four Weeks of Jan

29 janv. 2026, 07:01 UTC

Résultats

3i Group: Action's Like-For-Like Sales Growth Was 4.9%

29 janv. 2026, 07:01 UTC

Résultats

3i Group: Action Net Sales, Operating Ebitda Rose 16% and 14%

29 janv. 2026, 07:00 UTC

Résultats

3i Group NAV Per Shr Rose to 3,017 Pence

13 nov. 2025, 07:29 UTC

Résultats

3i Group: First Div Is Set at 50% of Total Div for FY2025

13 nov. 2025, 07:29 UTC

Résultats

3i Group PLC Declares Dividend of 36.5p

13 nov. 2025, 07:28 UTC

Résultats

3i Group Had Net Debt of GBP772M, Gearing of 3%

13 nov. 2025, 07:28 UTC

Résultats

3i Group Ended Period With Liquidity of GBP1.64B

3i Group PLC prévision

Objectif de Prix

By TipRanks

36.98% hausse

Prévisions sur 12 Mois

Moyen 3,105.33 GBX  36.98%

Haut 4,280 GBX

Bas 1,850 GBX

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

6 ratings

4

Achat

0

Maintien

2

Vente

Sentiment

By Acuity

16 / 26Classement par Indices

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos 3i Group PLC

3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, pharmaceuticals and biotechnology including specialty pharma, generics / OTC, drug delivery, and animal health; healthcare Services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in community facilities, as well as operational services such as outsourced support, cl
help-icon Live chat